0 patents currently held, every record listed here
5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
This portfolio holds none of the 5 US patents in force on its record. from the record
Of the 5 now held by other companies, 5 name Biointellisense Inc. as their current owner. Each row says so.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
none
Next term end
When these terms end
Each bar runs from grant to computed term end. 2012 to 2041.20182024203020362041
A dotted end marks a recorded terminal disclaimer this site has not resolved: the term can only be shorter than the bar, never longer.
Every computed term in this portfolio is shown above.Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
None of the currently held patents qualifies as notable.
Formerly held, still cited
Notable
Ends Jan 2031 · High confidence
The most cited patent in this portfolio, cited by 48 later US patents, top 25% of utility patents granted in 2012 in our data. Protection runs to 2031.
now held by Biointellisense, Inc.
Also notable
Ends Mar 2035 · High confidence
Granted 2019. Computed term ends 2035.
now held by Biointellisense, Inc.
Also notable
Ends Sep 2041 · High confidence
Granted 2024. Too new for citation comparison; protection runs to 2041.
now held by Biointellisense, Inc.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 16, 2027.
Recent changes
- 1 of the patents on this record was granted since Aug 19, 2026
Patents held now
Soonest term end first.
Also on record: 5 patents in force now held by others · 2 patents ended. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
1 terminal disclaimer is on file with no resolved reference. No cap is applied and none is guessed
1 computed term date comes from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.